84 results about "Vaginal flora" patented technology

A method and system for testing fluids from a patient is provided. In one embodiment, a portable device is configured with one or more testing modules adapted perform one or more tests on a fluid sample in order to determine if a patient has bacterial vaginosis. A timer module coupled to a sample transport is configured to move a vaginal fluid sample between one or more testing modules at various stages along a predetermined testing path. In an embodiment, the timer module is configured to move the vaginal fluid sample between the testing modules along a circular testing path. The vaginal fluid sample may be processed in sequential order over predetermined time periods with respect to the processing performed by the testing module in order to detect the presence of, or lack of, Lactobacilli in the patient's vaginal flora to determine whether or not the patient has bacterial vaginosis.

A method utilizing a dissolvable device for the internal delivery of medication and more particularly to the use of fibers or non-woven fabrics made of a safe polymer material incorporating a medication that is released by dissolution of the fibers or non-woven fabrics over time, and more particularly a treatment method for controlling or regulating the pH in the vagina by stabilizing and adjusting the pH in the vagina by minimizing the impact of the vaginal flora.

The invention relates to the medicines for gynecopathy, in particular to physiological balance liquid for adjusting microecology in vaginas of women, solving the problem that the traditional gynecological lotion kills probiotics while killing pathogens, thus causing vaginal flora imbalance and low immunity and further causing repeated vaginitis. The physiological balance liquid is formed by major materials, auxiliary materials and water, wherein the major materials include the following components according to mass concentration: 0.7-1% of sodium chloride, 0.01-0.04% of potassium chloride, 0.01-0.04% of calcium chloride, 0.01-0.04% of magnesium sulfate, 0.001-0.01% of manganese sulfate and 0.01-0.05% of glucose; and the auxiliary materials include the following components according to mass concentration: 0.1-1% of soy peptide, 0.001-0.01% of isoflavone, 0.05-0.6% of tea tree oil and 0.002-0.04% of carotene. The physiological balance liquid conforms to physiological conditions of the vagina mucosa, increases the absolute number of the lactobacillus, a predominant bacterium, reduces the pathogens, maintains the balance of microecology in vaginas and improves vaginal cleanliness and the immunity of the vagina mucosa, thus achieving the aims of preventing gynecological vagina inflammation and reducing the reoccurrence rate of gynecological vaginitis. The physiological balance liquid has good biocompatibility and no irritation or side effects and is safe.

The invention discloses a method for preparing a human vaginal microecological preparation-probiotics condom. The method is characterized in that probiotics are added to the front end of a condom or a stock solution by adopting the ecology theory of bacteria inhibition through probiotics, so that probiotics are fully and evenly distributed into female vaginas when men and women make love, thus the functions of restoring vaginal flora balance and self-cleaning are achieved; gynecological diseases such as bacterial vaginitis (BV), colpitis mycotica and trichomonas vaginitis are effectively treated and prevented. The method has the advantages that the method that the probiotics enter the vagina to adjust vaginal flora balance is simple and convenient, has both treating and protecting functions, is used for supporting the healthy energy, and is good in treatment effect, free of recurrence after curing, high in efficiency, economical, safe and wide in application range.

The invention relates to the application of a probiotic complex in the prevention and treatment of vaginitis. Prebiotic factors can singlely promote the reproduction of beneficial bacteria Lactobacillus and Bifidobacteria in the vagina, and inhibit the growth of vaginal pathogenic bacteria through space-occupying competition. At the same time, the reproduction of lactobacilli can secrete hydrogen peroxide to kill harmful bacteria. The reproduction of Lactobacillus can also produce a large amount of acidic components, maintain the normal pH value of the vagina, inhibit the growth of harmful bacteria, and regulate the structure of vaginal flora. The invention can effectively prevent and treat vaginitis.

The invention discloses a nifuratel-nysfungin soft capsule suppository. The nifuratel-nysfungin soft capsule suppository comprises 500mg of nifuratel, 200000IU of nysfungin, 8mg of promestriene, 25mg of carbomer, 700mg of glycerinum, 6mg of ethylparaben, 294mg of triethanolamine, 800mg of ethyl alcohol and 7.5g of water. The invention also discloses a preparation method of the nifuratel-nysfungin soft capsule suppository. The nifuratel-nysfungin soft capsule suppository can kill bacteria, mould and trichomonad, effectively protect lactobacillus and promote vaginal flora to restore balance, thus realizing the purpose of 'ecological treatment'; and the soft capsule suppository has both the dosage form characteristic of soft capsule (good stability of capsule core, capsule skin and drug) and local drug delivery characteristic of suppository.

The invention relates to the technical field of medical care, aims at solving the problem that vaginitis is repeatedly caused since the traditional gynecological lotion kills many probiotics while killing pathogenic bacteria and causes vaginal flora imbalance and low vaginal immunity, and provides a gynecological vaginal lotion for adjusting the female vaginal micro-ecosystem and a preparation method thereof. The preparation method comprises the following steps: adding natural perfume having 0.01-0.5 percent of the volume concentration of acidic water into the acidic water, disinfecting, and adjusting the pH value to be 3.5-5.5. According to the method, lactobacillus reproduction is promoted to achieve the aim of inhibiting pathogenic bacteria, the absolute number of dominant bacterium lactobacillus is increased, the number of pathogenic bacteria is reduced, the micro-ecological balance of vagina is maintained, the vaginal cleanness is improved, the vagina mucosa immunity is improved, the gynecological vaginal inflammation is prevented, and the recurrence rate of gynecological vaginitis is reduced. The gynecological vaginal lotion is safe, has a specific pH value range being 3.5-5.5, and is safer and more effective than those of other bacteriostatic agents and bactericides.

The invention studies the physiological action between vagina microorganisms and sperm cells with experimental means, and finds that certain vagina microorganisms can be specifically combined with sperms, so as to make sperms swim slower or even stop moving, or cause change in protein generation level of sperms to further affect the ability of sperms to be combined with eggs. Based on the findings, the invention determines a technical route for improving sperm motility by interfering with vaginal flora; microorganisms which can be well combined with sperms and do not affect basic physiological characters of sperms are selected out, adhesion of microorganisms harmful to sperms is prevented by means of the occupying function of the selected microorganisms, and therefore sperm motility can be improved, so as to relieve or treat infertility. Furthermore, probiotics microorganisms in a microbial agent are helpful for treatment of various diseases caused by vaginal flora dysbacteriosis, the treatment effect is remarkable, relapse probability is low, and popularization prospects are broad.

The present invention relates to the use of benzoic acid and / or its sodium salt in combination with saccharide(s) as active components in the manufacture of a vaginal composition for modulating vaginal flora and vaginal acidity, thereby maintaining the pH value of vaginal secretion within a range from 3.5 to 4.5; and the present invention further relates to a vaginal composition and a method for modulating and maintaining normal vaginal flora and vaginal acidity.